Related Experiment Video
Updated: Sep 23, 2025

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
Published on: June 6, 2020
HDL and Therapy
Ke Li1, Xianwei Xie2, Yansong Guo3,4,5,6,7
1Beijing Tiantan Hospital, China National Clinical Research Center of Neurological Diseases, Advanced Innovation Center for Human Brain Protection, The Capital Medical University, Beijing, China.
Insights
High-density lipoprotein (HDL) shows cardioprotective effects and targets cardiovascular diseases. Recombinant HDL (rHDL) and apolipoprotein mimetic peptides offer promising therapeutic avenues for various conditions.
Area of Science:
- Cardiovascular Science
- Nanomedicine
- Therapeutics
Background:
- High-density lipoprotein (HDL) possesses significant antiatherosclerosis and cardioprotective properties.
- HDL cholesterol (HDL-C) is a recognized therapeutic target for cardiovascular disease reduction.
- Recombinant HDL (rHDL) and apolipoprotein mimetic peptides represent emerging therapeutic strategies.
Purpose of the Study:
- To discuss the pleiotropic therapeutic effects of rHDL.
- To review the applications of rHDL as a nanovector.
- To examine clinical trial advances and future outlook for rHDL and mimetic peptide therapies.
Main Methods:
- Literature review on rHDL and apolipoprotein mimetic peptides.
- Discussion of rHDL's effects on atherogenesis, angiogenesis, platelets, and vascular and neurological diseases.
- Analysis of clinical trial data and therapeutic potential.
Main Results:
- rHDL exhibits pleiotropic therapeutic effects beyond its role in HDL.
- rHDL functions as a nanovector for antiatherosclerotic, antitumor, and diagnostic applications.
- Apolipoprotein mimetic peptides are in clinical assessment with promising therapeutic potential.
Conclusions:
- rHDL and apolipoprotein mimetic peptides hold significant promise for treating cardiovascular diseases and other conditions.
- Further clinical evaluation is warranted to fully realize the therapeutic potential of these agents.
- rHDL's versatility as a nanovector expands its therapeutic and diagnostic applications.
Abstract:
A wealth of evidence indicates that high-density lipoprotein assumes the unique antiatherosclerosis and other cardioprotective properties. Based on that, HDL-C has been considered as a promising therapy target to reduce the cardiovascular diseases. Recombinant HDL (rHDL) and apolipoprotein mimetic peptides emerge in recent years and have great potential in the future. Here we discussed the pleiotropic therapeutic effect of rHDL based on the effects of atherogenic, angiogenesis, platelet, vascular, and Alzheimer's disease. On the other hand, rHDL not only plays the key role as the major protein component of HDL, it is also used as a nanovector in antiatherosclerotic, antitumor, cardiovascular diagnosing and other therapeutic areas. Synthetic apolipoprotein mimetic peptides like apoA-I and and apoE mimetics have undergone clinical assessment, and we have also reviewed the advances of clinical trials and gave an outlook for the therapy of rHDL and mimetic peptides.
More Related Videos
07:21Electroencephalographic Signal Acquisition Framework for Neurodiverse: A Case Study of Dolphin-Assisted Therapy
Published on: June 27, 2025
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
Related Concept Videos
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Drug Therapy
Antianxiety Medications
Psychotherapy
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Humanistic Therapy
Couples Therapy
Core Principles and Techniques
Couples therapy often incorporates cognitive-behavioral principles to identify and modify negative...